We are dedicated to fight CVD in the ageing population
CVD is the leading cause of morbidity and mortality, with ageing being a primary risk factor. With the ageing of our population, the prevalence of CVD will only increase. This is particularly relevant for the Northern Netherlands, a region with a high incidence of risk factors and unfavorable socioeconomic circumstances.
Research grounded in care and society
Our investigators and doctors are well-embedded in societal organizations ensuring timely dissemination into clinical care and society. Our studies span from experimental to clinical research, interventions, and cohort studies.
We run intervention studies including pharmacological interventions, lifestyle interventions, and device interventions. Besides, we do cohort studies to identify prognostic factors in the general population and populations at high risk for CVD. We also investigate the role of co-morbidities such as renal disease, cancer, obesity and diabetes.
We contribute to a reduction in deaths due to CVD
Our translational approach and high quality research has contributed to a reduction in deaths due to CVD, thereby contributing to healthy ageing.